Natco Pharma's marketing partner gets US FDA nod for anti-cancer drug
Natco has tied up with Breckenridge Pharmaceutical Inc to market the product in the US.14-06-2021
14-06-2021
Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
NATCO receives approval for Carfilzomib Vials ANDA (generic for KYPROLIS(r)) in the US market14-06-2021
Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication for Board Meeting09-06-2021
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication for Board Meeting09-06-2021
Natco Pharma Ltd - 524816 - Closure of Trading Window
Please note that pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time TRADING WINDOW for dealing in the securities of the Company by the Employee(s) I Director(s) and their immediate relatives will be closed from 9th June, 2021 to 20th June, 20Zl (both days inclusive ). Trading window will be opened on Monday, the 21st day of June, 2021.08-06-2021
Natco Pharma Ltd - 524816 - Board Meeting Intimation for Audited Financial Results For FY 2020-21 And Interim Dividend, If Any
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/06/2021 ,inter alia, to consider and approve Audited Financial Results for FY 2020-21 and Interim Dividend, if any08-06-2021
Natco Pharma hits record highs on drug approvals
The stock opened at a 52-week high of 1,188.9524-05-2021
Natco Pharma gets USFDA nod for Lenalidomide capsules
Natco Pharma Limited has received the final approval of its Abbreviated New Drug Application (ANDA) for Lenalidomide capsules from the US Food and Dr22-05-2021
NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
NATCO receives USFDA approval for Lenalidomide Capsules22-05-2021
Natco Pharma Ltd - 524816 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
NATCO receives USFDA approval for Lenalidomide Capsules22-05-2021